Silvercrest Asset Management Group LLC Exagen Inc. Transaction History
Silvercrest Asset Management Group LLC
- $13.6 Billion
- Q1 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Exagen Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 531,767 shares of XGN stock, worth $3.69 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
531,767
Previous 535,017
0.61%
Holding current value
$3.69 Million
Previous $2.19 Million
12.95%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding XGN
# of Institutions
40Shares Held
6.17MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$10.5 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$6.19 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$3.41 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$3.37 Million0.0% of portfolio
-
Perkins Capital Management Inc423KShares$2.94 Million1.69% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $113M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...